Ibritumomab, known as Zevalin, represents the innovative form of targeted radiotherapy employed to treat certain kinds of non-Hodgkin's lymphoma , particularly recurring lymphomas. This is an monoclonal https://www.targetmol.com/compound/ibritumomab